Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest

Completed · Phase 2

Conditions studied: Cardiac Arrest

In brief

To study the effects of ubiquinol as a "metabolic resuscitator" in post-cardiac arrest.

Key facts

Study ID

NCT02934555

Run by

Beth Israel Deaconess Medical Center

People needed

48

Starts

2016-03-01

Expected to finish

2019-06-02

Last updated by the study team

2021-02-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (≥ 18 years)
• Cardiac arrest defined by cessation of pulse requiring chest compressions
• Not following commands after ROSC
• Admission to the ICU
• Naso/orogastric tube
• Ability to receive enteral medication

You may not qualify if…

• Protected populations (pregnant women, prisoners, the intellectual disabled)
• Current CoQ10 supplementation
• Anticipated death within 24 hours
• > 12 hours from ROSC to estimated randomization
• Jejunostomy tube (J-tube)

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.